• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

  • Home
  • About Us
    • Mission and History
    • Grace-Marie Turner bio
    • Who was Galen?
  • Activities
    • Core Activities
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

Bringing Rational Payment Structures to Cancer Treatment under Medicare

POSTED BY Galen Institute on August 20, 2004.

The new Medicare legislation enacted in December, 2003, continues to draw fire for its cost and structure, but the blanket criticism misses many of the important and necessary improvements it contains.


The Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA) contains critical changes to fix problems with the program, changes that get into the hardwiring of Medicare?s benefit-driven structure.



One such change involves the way Medicare Part B pays doctors for administering prescription drug therapy in their offices, including chemotherapy. Even though Medicare currently does not cover most outpatient drugs, it does pay physicians to administer some drug treatments in their offices to avoid the higher cost of hospitalization and to make receiving the drugs less inconvenient for patients. (Following enactment of MMA, Medicare will begin providing a general outpatient prescription drug benefit for all beneficiaries beginning in 2006.)

Click here to read the paper.

Filed Under: Uncategorized

Bringing Rational Payment Structures to Cancer Treatment under Medicare

POSTED BY Galen Institute on August 20, 2004.

The new Medicare legislation enacted in December, 2003, continues to draw fire for its cost and structure, but the blanket criticism misses many of the important and necessary improvements it contains.


The Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA) contains critical changes to fix problems with the program, changes that get into the hardwiring of Medicare?s benefit-driven structure.



One such change involves the way Medicare Part B pays doctors for administering prescription drug therapy in their offices, including chemotherapy. Even though Medicare currently does not cover most outpatient drugs, it does pay physicians to administer some drug treatments in their offices to avoid the higher cost of hospitalization and to make receiving the drugs less inconvenient for patients. (Following enactment of MMA, Medicare will begin providing a general outpatient prescription drug benefit for all beneficiaries beginning in 2006.)

Click here to read the paper.

Filed Under: Uncategorized

Primary Sidebar

Our Annual Report

Health Care Choices 20/20:

A Vision for the Future

SEARCH

Categories

  • Brian Blase
  • Consumer-Directed Care
  • Doug Badger
  • Grace-Marie Turner
  • Health Insurance
  • Health Policy Consensus Group
  • Health Savings Accounts
  • Innovation
  • Medicaid
  • Medicare
  • Newsletter
  • ObamaCare
  • Prescription Drugs
  • Published
    • Forbes
    • Fox Business
    • Health Affairs
    • LA Times
    • National Review
    • New York Post
    • RealClearHealth
    • Sun Sentinel
    • The Daily Signal
    • The Heritage Foundation
    • The Hill
    • The New York Times
    • The Wall Street Journal
    • The Washington Times
  • Reform Initiatives
  • State Issues
  • Uncategorized

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute at Donors. © 2023; · Log in